Epidermal kinetic alterations required to generate the psoriatic phenotype: A reappraisal

Cell Proliferation

Volumn 43, Issue 3, 2010, Pages 321-325

  Simonart, T ^a   Heenen, M ^a   Lejeune, O ^b,c  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIVISION; EPIDERMIS; HOMEOSTASIS; HUMAN; IMMUNOPATHOGENESIS; KERATINOCYTE; MEDLINE; PHENOTYPE; PSORIASIS; STEM CELL;

CELL DIFFERENTIATION; CELL PROLIFERATION; EPIDERMIS; FEEDBACK, PHYSIOLOGICAL; HOMEOSTASIS; HUMANS; KERATINOCYTES; MATHEMATICAL CONCEPTS; MODELS, THEORETICAL; PHENOTYPE; PSORIASIS; STEM CELLS;

EID: 77951695046     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2010.00672.x     Document Type: Article

References (30)

1. Schon MP, Boehncke WH (2005) Psoriasis. N. Engl. J. Med. 352, 1899 1912.
2. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445, 866 873.
3. Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370, 263 271.
4. Lejeune O, Simonart T (2008) Origin of threshold behaviour in psoriasis. Dermatology 217, 295 298.
5. Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, Rodijk-Olthuis D et al. (2008) Psoriasis is associated with increased beta-defensin genomic copy number. Nat. Genet. 40, 23 25.
6. Nair RP, Ruether A, Stuart PE, Jenisch S, Tejasvi T, Hiremagalore R et al. (2008) Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J. Invest. Dermatol. 128, 1653 1661.
7. Heenen M, Galand P, de Maertelaer V, Heenen PH (1987) Psoriasis: hyperproliferation cannot induce characteristic epidermal morphology. Cell Tissue Kinet. 20, 561 570.
8. Iizuka H, Honda H, Ishida-Yamamoto A (1997) Epidermal remodeling in psoriasis (II): a quantitative analysis of the epidermal architecture. J. Invest. Dermatol. 109, 806 810.
9. Heenen M (1998) On the morphogenesis of a psoriatic lesion. J. Invest. Dermatol. 111, 174.
10. Weinstein GD, McCullough JL, Ross PA (1985) Cell kinetic basis for pathophysiology of psoriasis. J. Invest. Dermatol. 85, 579 583.
11. Castelijns FA, Gerritsen MJ, van Vlijmen-Willems IM, Van Erp PE, van de Kerkhof PC (1999) The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis. J. Am. Acad. Dermatol. 40, 901 909.
12. Gelfant S (1976) The cell cycle in psoriasis: a reappraisal. Br. J. Dermatol. 95, 577 590.
13. Van Erp PE, De Mare S, Rijzewijk JJ, Van de Kerkhof PC, Bauer FW (1989) A sequential double immunoenzymic staining procedure to obtain cell kinetic information in normal and hyperproliferative epidermis. Histochem. J. 21, 343 347.
14. Franssen ME, Zeeuwen PL, Vierwinden G, van de Kerkhof PC, Schalkwijk J, van Erp PE (2005) Phenotypical and functional differences in germinative subpopulations derived from normal and psoriatic epidermis. J. Invest. Dermatol. 124, 373 383.
15. Clayton E, Doupé DP, Klein AM, Winton DJ, Simons BD, Jones PH (2007) A single type of progenitor cell maintains normal epidermis. Nature 446, 185 189.
16. Jones P, Simons BD (2008) Epidermal homeostasis: do committed progenitors work while stem cells sleep? Nature 9, 82 88.
17. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K et al. (2005) Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 11, 43 49.
18. Reischl J, Schwenke S, Beekman JM, Mrowietz U, Stürzebecher S, Heubach JF (2007) Increased expression of Wnt5a in psoriatic plaques. J. Invest. Dermatol. 127, 163 169.
19. Karlsson T, Mark EB, Henriksson R, Hedman H (2008) Redistribution of LRIG proteins in psoriasis. J. Invest. Dermatol. 128, 1192 1195.
20. Grabe N, Neuber K (2007) Simulating psoriasis by altering transit amplifying cells. Bioinformatics 23, 1309 1312.
21. Wrone-Smith T, Mitra RS, Thompson CB, Jasty R, Castle VP, Nickoloff BJ (1997) Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am. J. Pathol. 151, 1321 1329.
22. Laporte M, Galand P, Fokan D, de Graef C, Heenen M (2000) Apoptosis in established and healing psoriasis. Dermatology 200, 314 316.
23. Heenen M, Simonart T (2006) Biologic agents and psoriatic epidermis: what are we ultimately targeting? Dermatology 212, 321.
24. Heenen M, Simonart T (2008) Apoptosis in psoriatic epidermis. J. Cutan. Pathol. 35, 346.
25. Savill NJ (2003) Mathematical models of hierarchically structured cell populations under equilibrium with application to the epidermis. Cell Prolif. 36, 1 26.
26. Klein AM, Doupé DP, Jones PH, Simons BD (2007) Kinetics of cell division in epidermal maintenance. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 76, 021910.
27. van de Kerkhof PC (2007) The evolution of the psoriatic lesion. Br. J. Dermatol. 157, 4 15.
28. Hennings H, Elgjo K (1970) Epidermal regeneration after cellophane tape stripping of hairless mouse skin. Cell Tissue Kinet. 3, 243 252.
29. Fisher LB, Maibach HI (1972) Physical occlusion controlling epidermal mitosis. J. Invest. Dermatol. 59, 106 108.
30. Gottlieb AB, Staiano-Coico L, Cohen SR, Varghese M, Carter DM (1990) Occlusive hydrocolloid dressings decrease keratinocyte population growth fraction and clinical scale and skin thickness in active psoriatic plaques. J. Dermatol. Sci. 1, 93 96.